Edition:
India

Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

61.16USD
1:14am IST
Change (% chg)

$-0.61 (-0.99%)
Prev Close
$61.77
Open
$61.84
Day's High
$62.26
Day's Low
$61.08
Volume
18,691
Avg. Vol
70,696
52-wk High
$106.23
52-wk Low
$57.26

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.61 September 13 Nov 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 4 4 4 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 2.25 2.43

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 7 62.31 67.41 53.29 49.54
Quarter Ending Mar-20 2 37.52 37.81 37.24 --
Year Ending Sep-19 7 219.66 228.11 206.93 245.84
Year Ending Sep-20 7 203.87 244.30 177.40 183.06
Earnings (per share)
Quarter Ending Sep-19 7 0.61 1.05 0.26 0.57
Quarter Ending Mar-20 2 -0.71 -0.39 -1.03 --
Year Ending Sep-19 7 2.25 3.00 1.87 3.36
Year Ending Sep-20 7 -0.15 1.87 -1.56 0.47

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-19 40.88 39.63 1.25 3.06
Quarter Ending Dec-18 71.27 69.89 1.38 1.94
Quarter Ending Sep-18 69.02 67.21 1.82 2.63
Quarter Ending Jun-18 56.93 57.26 0.33 0.58
Quarter Ending Mar-18 40.77 44.05 3.28 8.05

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-19 62.31 63.54 63.67 63.67 49.54
Quarter Ending Mar-20 37.52 37.52 37.52 37.52 --
Year Ending Sep-19 219.66 222.40 222.59 222.59 245.84
Year Ending Sep-20 203.87 207.08 208.90 208.90 183.06

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-19 0 2 1 3
Quarter Ending Mar-20 0 0 0 0
Year Ending Sep-19 0 2 1 3
Year Ending Sep-20 0 2 0 4
Earnings